L. Meng

CD19/CD22 CAR T cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas: Combined CAR T Cell Therapy and Transplantation.

Jianfeng Zhou, X. Yi, Tongcun Zhang, 2021, Transplantation and cellular therapy.

The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis

L. Meng, Jianfeng Huang, P. Luo, 2022, Investigational New Drugs.

The efficacy and safety of immune checkpoint inhibitor plus chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis

L. Meng, Jianfeng Huang, P. Luo, 2022, Investigational New Drugs.

Randomized phase III study of canfosfamide (C, TLK286) plus pegylated liposomal doxorubicin (PLD) versus PLD as second-line therapy in platinum (P) refractory or resistant ovarian cancer (OC).

I. Vergote, M. Jones, P. Rose, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.